Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2009
An effective vaccine may be the only way to stop the HIV pandemic. The purpose of this study is to determine the safety of and immune response to the DNA vaccine, PENNVAX-B with or without an IL-12 adjuvant when given using electroporation.
Epistemonikos ID: 82dd988119b0756af620679361a7f68a5a62be04
First added on: Dec 01, 2021